NO20021337D0 - 4-benzylaminoquinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlersom inneholder disse forbindelser og deres anvendelse - Google Patents

4-benzylaminoquinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlersom inneholder disse forbindelser og deres anvendelse

Info

Publication number
NO20021337D0
NO20021337D0 NO20021337A NO20021337A NO20021337D0 NO 20021337 D0 NO20021337 D0 NO 20021337D0 NO 20021337 A NO20021337 A NO 20021337A NO 20021337 A NO20021337 A NO 20021337A NO 20021337 D0 NO20021337 D0 NO 20021337D0
Authority
NO
Norway
Prior art keywords
compounds
preparation
heteroanalogs
benzylaminoquinoline
conjugates
Prior art date
Application number
NO20021337A
Other languages
English (en)
Other versions
NO20021337L (no
Inventor
Armin Hofmeister
Eugen Falk
Heinz-Werner Kleeman
Hans-Willi Jansen
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999145385 external-priority patent/DE19945385A1/de
Priority claimed from DE2000128193 external-priority patent/DE10028193A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20021337D0 publication Critical patent/NO20021337D0/no
Publication of NO20021337L publication Critical patent/NO20021337L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021337A 1999-09-22 2002-03-18 4-benzylaminokinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlerinneholdende disse forbindelser og deres anvendelse NO20021337L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999145385 DE19945385A1 (de) 1999-09-22 1999-09-22 Substituierte 4-Benzylaminochinoline und ihre Heteroanlagen, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE2000128193 DE10028193A1 (de) 2000-06-09 2000-06-09 Substituierte 4-Benzylamminochinoline und ihre Heteroanalogen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika, sowie sie enthaltende Medikamente
PCT/EP2000/008691 WO2001021642A1 (de) 1999-09-22 2000-09-06 4-benzylaminochinoline konjugaten mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung

Publications (2)

Publication Number Publication Date
NO20021337D0 true NO20021337D0 (no) 2002-03-18
NO20021337L NO20021337L (no) 2002-05-15

Family

ID=26005994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021337A NO20021337L (no) 1999-09-22 2002-03-18 4-benzylaminokinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlerinneholdende disse forbindelser og deres anvendelse

Country Status (26)

Country Link
US (1) US6339077B1 (no)
EP (1) EP1218401B1 (no)
JP (1) JP4833471B2 (no)
KR (1) KR20030010575A (no)
CN (1) CN1158299C (no)
AT (1) ATE269352T1 (no)
AU (1) AU779412B2 (no)
BR (1) BR0014233A (no)
CA (1) CA2385445A1 (no)
CZ (1) CZ2002992A3 (no)
DE (1) DE50006842D1 (no)
DK (1) DK1218401T3 (no)
EE (1) EE200200143A (no)
ES (1) ES2218222T3 (no)
HK (1) HK1049169B (no)
HR (1) HRP20020238A2 (no)
HU (1) HUP0203045A3 (no)
IL (1) IL148739A0 (no)
NO (1) NO20021337L (no)
NZ (1) NZ517899A (no)
PL (1) PL353992A1 (no)
PT (1) PT1218401E (no)
RU (1) RU2247125C2 (no)
SK (1) SK3862002A3 (no)
WO (1) WO2001021642A1 (no)
YU (1) YU19302A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576644B2 (en) 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase
ITMI20021025A1 (it) * 2002-05-14 2003-11-14 Nicox Sa Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale
CZ301037B6 (cs) * 2007-09-06 2009-10-21 Vysoká škola chemicko-technologická v Praze Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy
WO2010111348A1 (en) * 2009-03-24 2010-09-30 Abbott Laboratories Process for preparing antiviral compound
WO2011123693A1 (en) * 2010-04-02 2011-10-06 Senomyx, Inc. Sweet flavor modifier
BR112014003285B1 (pt) 2011-08-12 2020-01-14 Firmenich Incorporated modificador de sabor doce
WO2016073251A1 (en) 2014-11-07 2016-05-12 Senomyx, Inc. Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
JPH0667846B2 (ja) * 1989-04-28 1994-08-31 一 滝川 利胆剤
TW289021B (no) * 1993-05-08 1996-10-21 Hoechst Ag
IT1274000B (it) * 1994-04-06 1997-07-14 Alfa Wassermann Spa Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
DE4432708A1 (de) 1994-09-14 1996-03-21 Hoechst Ag Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
JPH09315979A (ja) * 1996-05-24 1997-12-09 Tokyo Tanabe Co Ltd 利胆剤
AU7552198A (en) * 1997-06-11 1998-12-30 Sankyo Company Limited Benzylamine derivatives

Also Published As

Publication number Publication date
HUP0203045A2 (hu) 2003-01-28
EE200200143A (et) 2003-04-15
YU19302A (sh) 2004-11-25
JP2003510255A (ja) 2003-03-18
CN1158299C (zh) 2004-07-21
CZ2002992A3 (cs) 2002-06-12
JP4833471B2 (ja) 2011-12-07
RU2247125C2 (ru) 2005-02-27
ES2218222T3 (es) 2004-11-16
HK1049169B (zh) 2005-04-22
NO20021337L (no) 2002-05-15
PT1218401E (pt) 2004-10-29
NZ517899A (en) 2004-03-26
DE50006842D1 (de) 2004-07-22
WO2001021642A1 (de) 2001-03-29
US6339077B1 (en) 2002-01-15
SK3862002A3 (en) 2003-01-09
EP1218401A1 (de) 2002-07-03
HRP20020238A2 (en) 2004-04-30
IL148739A0 (en) 2002-09-12
HK1049169A1 (en) 2003-05-02
AU7515600A (en) 2001-04-24
ATE269352T1 (de) 2004-07-15
BR0014233A (pt) 2002-05-21
HUP0203045A3 (en) 2004-06-28
KR20030010575A (ko) 2003-02-05
AU779412B2 (en) 2005-01-20
CN1374968A (zh) 2002-10-16
EP1218401B1 (de) 2004-06-16
CA2385445A1 (en) 2001-03-29
DK1218401T3 (da) 2004-10-04
PL353992A1 (en) 2003-12-15

Similar Documents

Publication Publication Date Title
NO20040547L (no) Amino-ftalazinonderivater aktive som kinaseinhibitorer, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende disse.
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
CY1114708T1 (el) Παραγωγα πυραζολο-κιναζολινης, διαδικασια για την παρασκευη τους και η χρηση τους ως αναστολεων κινασης
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
CY1108246T1 (el) ΠΑΡΑΓΩΓΑ 1Η-ΘΕΙΕΝΟ[2,3-c] ΠΥΡΑΖΟΛΗΣ ΧΡΗΣΙΜΑ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΚΙΝΑΣΗΣ
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
NO20063277L (no) Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
NO20021337D0 (no) 4-benzylaminoquinolinkonjugater med gallesyre og deres heteroanaloger, fremgangsmåte for deres fremstilling, legemidlersom inneholder disse forbindelser og deres anvendelse
MXPA05012369A (es) Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina.
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
MY126998A (en) Substituted pyrroles.
PT952157E (pt) Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
JO2733B1 (en) Viral inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application